Government of CanadaPublic Health Agency of Canada / Agence de santé publique du Canada
   
Skip all navigation -accesskey z Skip to sidemenu -accesskey x Skip to main menu -accesskey m  
Français Contact Us Help Search Canada Site
PHAC Home Centres Publications Guidelines A-Z Index
Child Health Adult Health Seniors Health Surveillance Health Canada
   
    Public Health Agency of Canada (PHAC)
Canada Communicable Disease Report

 

 

Volume: 27S1 • July 2001

Report of the Xenotransplantation Surveillance Workshop


Infection Control Database and
Sample Archiving

Ottawa, Ontario
March 31, 2000

Adobe Downloadable Document PDF (327 KB)


Table of Contents

OVERVIEW

  • Why an Enhanced Surveillance System for Xenotransplantation in Canada?

I: INTRODUCTION

  • Background to the Current Regulatory Framework for Xenotransplantation in Canada
  • Adverse Event Reporting in Canada
  • Potential Attributes of an Enhanced Surveillance Scheme
  • Enhanced Xenotransplantation Surveillance in Other Nations
  • The Issue of Endemic Viruses
  • The Issue of Endogenous Viruses
  • Published Adverse Events in Xenograft Recipients
  • Infectious Disease Risks of Endemic and Endogenous Porcine Viruses

II: SURVEY RESULTS AND DISCUSSION

  • Patient Registry and Adverse Event Reporting Database
  • Definition of Adverse Event for Xenotransplantation
  • Linking Adverse Events to Xenozoonosis
  • Criteria for Follow-Up Investigation of Potential Zoonosis
  • Time Lines for Reporting Data and Adverse Events to Registry
  • Sample Archiving
  • Schedule for Recipient Archiving/Testing
  • Pre-Clinical Work-Up on the Source Herd
  • Surrogate Markers
  • Testing for Unknown Pig Infectious Agents
  • Xenozoonoses Outbreak Responses

III: CONCLUSIONS AND SUMMARY

IV: REFERENCES

V: APPENDICES



 

This report was compiled by Dr. Marian Laderoute from the results of a written survey completed by participants at a Health Canada sponsored Xenotransplantation Surveillance Workshop, March 2000, and from her analysis of the current literature on xenotransplantation. The issue of xenotransplantation is characterized by many different views. Health Canada supported this workshop in order to assist in promoting discussion; however the opinions expressed by Dr. Laderoute and the participants do not reflect a Health Canada policy on the issue.

Dr. Laderoute is the Research Manager, Blood Zoonotics Unit, Bloodborne Pathogens Division. All correspondence should be addressed to Dr. Laderoute at the following address:

Dr. Marian Laderoute
Research Manager, Blood Zoonotics Unit
Bloodborne Pathogens Division
Bureau of Infectious Diseases
Centre for Infectious Disease Prevention and Control
Health Canada, LCDC Building #6, Room 1420
Tunney's Pasture AL 060 1E2
Ottawa, Ontario K1A 0L2

tel: (613) 941-6087
fax: (613) 952-6668
e-mail: marian_laderoute@hc-sc.gc.ca

[Table of Contents] [Next]

 

Last Updated: 2001-08-09 Top